What is Revero?
Revero operates a virtual-first clinic that merges nutritional therapy and clinical expertise with advanced machine learning and digital tools. The company's AI-based medical nutritional therapy is designed to identify and eliminate foods that contribute to disease pathways, personalizing treatment plans based on biomarkers and clinical outcomes to address the root causes of chronic diseases.
How much funding has Revero raised?
Revero has raised a total of $5M across 1 funding round:
Angel/Seed
$5M
Angel/Seed (2022): $5M with participation from Goodwater Capital, Think + Ventures, A16Z Scout, and CapitalX
Key Investors in Revero
Goodwater Capital
Goodwater Capital is a consumer tech investment firm focused on empowering entrepreneurs and driving positive change, with a portfolio spanning financial services, retail, and healthcare.
Think + Ventures
Think+ is an early-stage venture capital firm based in Palo Alto, California, providing financial services and funding to emerging companies.
CapitalX
CapitalX is a Singapore-based company operating within the restaurant industry, indicating a potential strategic interest in Revero's consumer-facing health solutions.
What's next for Revero?
The substantial enterprise-level funding Revero has garnered positions it for significant scaling and further development of its AI-driven chronic disease management platform. This strategic investment will likely fuel expansion into new markets, enhance its technological capabilities, and broaden its reach to patients seeking personalized, data-driven health solutions. The company's focus on integrating nutritional science with cutting-edge technology suggests a trajectory towards becoming a leader in preventative and chronic care.
See full Revero company page
